IHE was created on 2006-05-01 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 624.31m in AUM and 40 holdings. IHE tracks a broad-based", cap-weighted index of US pharmaceutical companies.
Current Value
$66.821 Year Return
Current Value
$66.821 Year Return
Assets Under Management
$596.23M
Div Yield %
1.99%
P/E Ratio
23.25
Net Asset Value
$66.74
Expense Ratio
0.39%
1Y ETF Return
0.16%
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LLY | 60.90% | $692.74B | +23.14% | 0.71% |
VTRS | 50.61% | $15.58B | +39.13% | 3.70% |
JAZZ | 49.38% | $7.06B | -1.23% | 0.00% |
TMO | 49.34% | $194.74B | +5.54% | 0.30% |
REGN | 48.64% | $81.82B | -6.79% | 0.00% |
OGN | 48.45% | $3.76B | +32.28% | 7.69% |
RCUS | 47.83% | $1.33B | +5.07% | 0.00% |
JNJ | 47.10% | $368.37B | +1.24% | 3.18% |
BIO | 46.20% | $8.98B | +4.73% | 0.00% |
RARE | 45.66% | $4.17B | +16.19% | 0.00% |
INVA | 45.48% | $1.20B | +42.14% | 0.00% |
ALDX | 44.25% | $294.18M | +102.46% | 0.00% |
AMGN | 43.91% | $150.48B | +6.52% | 3.20% |
UA | 42.76% | $3.71B | +18.70% | 0.00% |
BCRX | 42.69% | $1.49B | +41.37% | 0.00% |
CRNX | 42.65% | $5.12B | +84.27% | 0.00% |
BDX | 42.41% | $64.35B | -5.72% | 1.71% |
AXGN | 42.38% | $561.11M | +113.93% | 0.00% |
ZTS | 42.24% | $79.21B | -1.77% | 0.98% |
DAWN | 42.22% | $1.36B | +13.42% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NTIC | -0.07% | $132.27M | +24.98% | 2.02% |
HIHO | 0.10% | $8.63M | 0.00% | 6.12% |
LTM | -0.26% | $8.51B | -100.00% | <0.01% |
NHTC | 0.45% | $61.83M | +0.19% | 14.81% |
CASI | 0.48% | $71.56M | -6.32% | 0.00% |
SAVA | 0.68% | $1.35B | +25.50% | 0.00% |
IMNN | -0.69% | $10.02M | -22.89% | 0.00% |
MCK | 0.70% | $78.15B | +35.51% | 0.42% |
STG | -0.78% | $35.67M | +7.92% | 0.00% |
PRPO | 0.87% | $9.10M | -13.65% | 0.00% |
EDR | 0.99% | $9.01B | +19.26% | 0.82% |
TCTM | -1.28% | $8.10M | -42.99% | 0.00% |
CBOE | -1.49% | $21.46B | +15.84% | 1.11% |
SCKT | -1.62% | $10.88M | +15.32% | 0.00% |
XOS | -1.67% | $30.51M | -57.24% | 0.00% |
MNR | -1.99% | $1.66B | -10.71% | 15.90% |
SMC | 2.16% | $383.35M | +97.26% | 0.00% |
BCAN | 2.18% | $72.87M | -99.75% | 0.00% |
TEM | -2.27% | $8.50B | 0.00% | 0.00% |
WHLM | 2.27% | $17.64M | -29.34% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -30.20% | $16.69M | -11.56% | 0.00% |
VIRT | -5.26% | $3.17B | +110.38% | 2.60% |
RAMP | -5.12% | $1.86B | -16.17% | 0.00% |
BACK | -4.03% | $1.76M | -32.90% | 0.00% |
BTCT | -4.03% | $42.61M | +353.33% | 0.00% |
QTTB | -3.68% | $354.34M | +188.64% | 0.00% |
UUU | -3.42% | $4.97M | -41.89% | 0.00% |
VERX | -2.97% | $7.99B | +89.70% | 0.00% |
TEM | -2.27% | $8.50B | 0.00% | 0.00% |
MNR | -1.99% | $1.66B | -10.71% | 15.90% |
XOS | -1.67% | $30.51M | -57.24% | 0.00% |
SCKT | -1.62% | $10.88M | +15.32% | 0.00% |
CBOE | -1.49% | $21.46B | +15.84% | 1.11% |
TCTM | -1.28% | $8.10M | -42.99% | 0.00% |
STG | -0.78% | $35.67M | +7.92% | 0.00% |
IMNN | -0.69% | $10.02M | -22.89% | 0.00% |
LTM | -0.26% | $8.51B | -100.00% | <0.01% |
NTIC | -0.07% | $132.27M | +24.98% | 2.02% |
HIHO | 0.10% | $8.63M | 0.00% | 6.12% |
NHTC | 0.45% | $61.83M | +0.19% | 14.81% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 85.24% | $592.06M | 0.36% |
FHLC | 83.83% | $2.73B | 0.084% |
VHT | 83.66% | $17.06B | 0.1% |
IYH | 83.37% | $3.19B | 0.39% |
XLV | 81.74% | $38.41B | 0.09% |
IXJ | 81.44% | $3.89B | 0.41% |
XPH | 78.88% | $157.87M | 0.35% |
FXH | 76.48% | $1.15B | 0.62% |
IBB | 71.37% | $6.66B | 0.45% |
RSPH | 70.18% | $885.96M | 0.4% |
BBH | 68.90% | $397.87M | 0.35% |
PINK | 68.82% | $161.15M | 0.5% |
FBT | 67.81% | $1.11B | 0.56% |
PBE | 67.66% | $258.53M | 0.58% |
XBI | 66.37% | $6.58B | 0.35% |
PTH | 66.32% | $143.31M | 0.6% |
GNOM | 60.84% | $70.59M | 0.5% |
JVAL | 58.71% | $693.47M | 0.12% |
QQQJ | 57.26% | $698.04M | 0.15% |
SMMV | 57.07% | $321.07M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBC | -0.07% | $1.39B | 0.87% |
BCD | 0.19% | $245.02M | 0.3% |
BILZ | 0.40% | $563.02M | 0.14% |
MINT | -0.49% | $11.62B | 0.35% |
SGOV | 0.68% | $27.53B | 0.09% |
CLOI | 0.71% | $715.40M | 0.4% |
PDBC | -0.99% | $4.40B | 0.59% |
GSG | -1.11% | $914.42M | 0.75% |
GCC | 1.20% | $133.23M | 0.55% |
SHV | 1.51% | $18.13B | 0.15% |
TBIL | 1.76% | $4.38B | 0.15% |
JBBB | 1.96% | $1.26B | 0.49% |
XHLF | 2.06% | $874.27M | 0.03% |
KRBN | -2.08% | $242.47M | 0.85% |
KCCA | -2.13% | $220.51M | 0.87% |
HDRO | -2.25% | $164.26M | 0.3% |
IVOL | -2.38% | $548.70M | 1.02% |
CMDY | 2.39% | $279.14M | 0.28% |
KMLM | -3.48% | $353.87M | 0.9% |
BSCO | 3.50% | $2.35B | 0.1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -37.37% | $195.31M | 0.85% |
BTAL | -29.20% | $388.04M | 1.43% |
TPMN | -26.26% | $40.60M | 0.65% |
USDU | -22.30% | $201.97M | 0.5% |
TAIL | -21.94% | $67.98M | 0.59% |
UUP | -18.82% | $309.25M | 0.77% |
DBA | -15.88% | $755.88M | 0.93% |
SOYB | -12.79% | $27.32M | 0.22% |
USCI | -12.23% | $185.47M | 1.07% |
DBO | -10.90% | $217.57M | 0.77% |
DBE | -10.63% | $50.13M | 0.77% |
CORN | -10.43% | $61.12M | 0.2% |
WEAT | -10.07% | $120.27M | 0.28% |
EQLS | -9.71% | $76.08M | 1% |
COMT | -9.33% | $829.06M | 0.48% |
CTA | -9.06% | $350.27M | 0.78% |
HIGH | -7.95% | $302.78M | 0.51% |
FTGC | -5.81% | $2.17B | 1.02% |
BOXX | -5.55% | $4.43B | 0.1949% |
UNG | -4.78% | $908.80M | 1.06% |
SeekingAlpha
While the drop has resulted in extreme underperformance versus the S&P 500, it has also resulted in the sector's weight in the S&P 500 falling dramatically.
SeekingAlpha
Many investors are now assessing how a new administration will impact the economy and markets. TD Asset Management's Justin Flowerday discusses the possible market drivers going forward.
SeekingAlpha
The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.
SeekingAlpha
Healthcare companies often grab headlines for their drug innovations. But itâs notoriously difficult to handicap outcomes, and we think investors' focus should be on business fundamentals.
SeekingAlpha
By Shannon L. Saccocia, CFAThe rush into risk assets could last through the end of the year, but thereafter the outlook becomes more complicated.After...
SeekingAlpha
Trade and investment, tax, immigration, and fiscal policies, and his approach to the Fed may impact some investments. Read more here.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.